OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
20
Results
Show all
Save search
Copy query
Show results for
Unknown
(20)
Publication Date
Release Date
2024
(3)
2020
(3)
2018
(3)
2022
(2)
2017
(2)
2016
(2)
2023
(1)
2021
(1)
2019
(1)
2015
(1)
2013
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Delivery of miR-34a by chitosan/PLGA nanoplexes for the anticancer treatment of multiple myeloma.
Not available
S-EPMC4665167
|
biostudies-literature
Cite
Next-generation sequencing analysis of receptor-type tyrosine kinase genes in surgically resected colon cancer: identification of gain-of-function mutations in the RET proto-oncogene.
Not available
S-EPMC5905113
|
biostudies-literature
Cite
Detection of chronic lymphocytic leukemia subpopulations in peripheral blood by phage ligands of tumor immunoglobulin B cell receptors.
Not available
S-EPMC7862058
|
biostudies-literature
Cite
Folding intermediate states of the parallel human telomeric G-quadruplex DNA explored using Well-Tempered Metadynamics.
Not available
S-EPMC7035250
|
biostudies-literature
Cite
A Fhit-mimetic peptide suppresses annexin A4-mediated chemoresistance to paclitaxel in lung cancer cells.
Not available
S-EPMC5058653
|
biostudies-literature
Cite
The receptor protein tyrosine phosphatase PTPRJ negatively modulates the CD98hc oncoprotein in lung cancer cells.
Not available
S-EPMC5955124
|
biostudies-literature
Cite
Proteomic analysis of protein purified derivative of Mycobacterium bovis.
Not available
S-EPMC5376687
|
biostudies-literature
Cite
MicroRNA let-7g acts as tumor suppressor and predictive biomarker for chemoresistance in human epithelial ovarian cancer.
Not available
S-EPMC6450929
|
biostudies-literature
Cite
Unraveling the impact of different liposomal formulations on the plasma protein corona composition might give hints on the targeting capability of nanoparticles.
Not available
S-EPMC11334990
|
biostudies-literature
Cite
Genetic variants associated with Fabry disease progression despite enzyme replacement therapy.
Not available
S-EPMC5746088
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets